FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998955107> ?p ?o ?g. }

• W2998955107 endingPage "798" @default.
• W2998955107 startingPage "788" @default.
• W2998955107 abstract "Abstract Aims/hypothesis We examined whether candidate biomarkers in serum or urine can improve the prediction of renal disease progression in type 1 diabetes beyond prior eGFR, comparing their performance with urinary albumin/creatinine ratio (ACR). Methods From the population-representative Scottish Diabetes Research Network Type 1 Bioresource (SDRNT1BIO) we sampled 50% and 25% of those with starting eGFR below and above 75 ml min −1 [1.73 m] −2 , respectively ( N = 1629), and with median 5.1 years of follow-up. Multiplexed ELISAs and single molecule array technology were used to measure nine serum biomarkers and 13 urine biomarkers based on our and others’ prior work using large discovery and candidate studies. Associations with final eGFR and with progression to <30 ml min −1 [1.73] m −2 , both adjusted for baseline eGFR, were tested using linear and logistic regression models. Parsimonious biomarker panels were identified using a penalised Bayesian approach, and their performance was evaluated through tenfold cross-validation and compared with using urinary ACR and other clinical record data. Results Seven serum and seven urine biomarkers were strongly associated with either final eGFR or progression to <30 ml min −1 [1.73 m] −2 , adjusting for baseline eGFR and other covariates (all at p <2.3 × 10 −3 ). Of these, associations of four serum biomarkers were independent of ACR for both outcomes. The strongest associations with both final eGFR and progression to <30 ml min −1 [1.73 m] −2 were for serum TNF receptor 1, kidney injury molecule 1, CD27 antigen, α-1-microglobulin and syndecan-1. These serum associations were also significant in normoalbuminuric participants for both outcomes. On top of baseline covariates, the r 2 for prediction of final eGFR increased from 0.702 to 0.743 for serum biomarkers, and from 0.702 to 0.721 for ACR alone. The area under the receiver operating characteristic curve for progression to <30 ml min −1 [1.73 m] −2 increased from 0.876 to 0.953 for serum biomarkers, and to 0.911 for ACR alone. Other urinary biomarkers did not outperform ACR. Conclusions/interpretation A parsimonious panel of serum biomarkers easily measurable along with serum creatinine may outperform ACR for predicting renal disease progression in type 1 diabetes, potentially obviating the need for urine testing." @default.
• W2998955107 created "2020-01-23" @default.
• W2998955107 creator A5005414020 @default.
• W2998955107 creator A5029261723 @default.
• W2998955107 creator A5039750697 @default.
• W2998955107 creator A5044306241 @default.
• W2998955107 creator A5052273407 @default.
• W2998955107 creator A5052988371 @default.
• W2998955107 creator A5064568845 @default.
• W2998955107 creator A5071230363 @default.
• W2998955107 creator A5073182776 @default.
• W2998955107 creator A5077228809 @default.
• W2998955107 creator A5077595764 @default.
• W2998955107 creator A5082071435 @default.
• W2998955107 creator A5084768303 @default.
• W2998955107 creator A5088134928 @default.
• W2998955107 date "2020-01-08" @default.
• W2998955107 modified "2023-10-16" @default.
• W2998955107 title "Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes" @default.
• W2998955107 cites W1492754188 @default.
• W2998955107 cites W1802508672 @default.
• W2998955107 cites W1877880381 @default.
• W2998955107 cites W1980600137 @default.
• W2998955107 cites W1986672307 @default.
• W2998955107 cites W1987223022 @default.
• W2998955107 cites W2003056396 @default.
• W2998955107 cites W2010520337 @default.
• W2998955107 cites W2015754438 @default.
• W2998955107 cites W2110135514 @default.
• W2998955107 cites W2125327064 @default.
• W2998955107 cites W2155965977 @default.
• W2998955107 cites W2165817472 @default.
• W2998955107 cites W2271842806 @default.
• W2998955107 cites W2533121585 @default.
• W2998955107 cites W2555966059 @default.
• W2998955107 cites W2577537660 @default.
• W2998955107 cites W2731461838 @default.
• W2998955107 cites W2790272775 @default.
• W2998955107 cites W2846658630 @default.
• W2998955107 cites W2895638174 @default.
• W2998955107 cites W2947792589 @default.
• W2998955107 cites W2954382701 @default.
• W2998955107 cites W2970627343 @default.
• W2998955107 doi "https://doi.org/10.1007/s00125-019-05081-8" @default.
• W2998955107 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7054370" @default.
• W2998955107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31915892" @default.
• W2998955107 hasPublicationYear "2020" @default.
• W2998955107 type Work @default.
• W2998955107 sameAs 2998955107 @default.
• W2998955107 citedByCount "24" @default.
• W2998955107 countsByYear W29989551072020 @default.
• W2998955107 countsByYear W29989551072021 @default.
• W2998955107 countsByYear W29989551072022 @default.
• W2998955107 countsByYear W29989551072023 @default.
• W2998955107 crossrefType "journal-article" @default.
• W2998955107 hasAuthorship W2998955107A5005414020 @default.
• W2998955107 hasAuthorship W2998955107A5029261723 @default.
• W2998955107 hasAuthorship W2998955107A5039750697 @default.
• W2998955107 hasAuthorship W2998955107A5044306241 @default.
• W2998955107 hasAuthorship W2998955107A5052273407 @default.
• W2998955107 hasAuthorship W2998955107A5052988371 @default.
• W2998955107 hasAuthorship W2998955107A5064568845 @default.
• W2998955107 hasAuthorship W2998955107A5071230363 @default.
• W2998955107 hasAuthorship W2998955107A5073182776 @default.
• W2998955107 hasAuthorship W2998955107A5077228809 @default.
• W2998955107 hasAuthorship W2998955107A5077595764 @default.
• W2998955107 hasAuthorship W2998955107A5082071435 @default.
• W2998955107 hasAuthorship W2998955107A5084768303 @default.
• W2998955107 hasAuthorship W2998955107A5088134928 @default.
• W2998955107 hasBestOaLocation W29989551071 @default.
• W2998955107 hasConcept C126322002 @default.
• W2998955107 hasConcept C126894567 @default.
• W2998955107 hasConcept C134018914 @default.
• W2998955107 hasConcept C143998085 @default.
• W2998955107 hasConcept C151956035 @default.
• W2998955107 hasConcept C159641895 @default.
• W2998955107 hasConcept C185592680 @default.
• W2998955107 hasConcept C2776174234 @default.
• W2998955107 hasConcept C2777180221 @default.
• W2998955107 hasConcept C2778653478 @default.
• W2998955107 hasConcept C2780026642 @default.
• W2998955107 hasConcept C2780306776 @default.
• W2998955107 hasConcept C2781197716 @default.
• W2998955107 hasConcept C2908647359 @default.
• W2998955107 hasConcept C55493867 @default.
• W2998955107 hasConcept C555293320 @default.
• W2998955107 hasConcept C71924100 @default.
• W2998955107 hasConcept C77411442 @default.
• W2998955107 hasConcept C90924648 @default.
• W2998955107 hasConcept C99454951 @default.
• W2998955107 hasConceptScore W2998955107C126322002 @default.
• W2998955107 hasConceptScore W2998955107C126894567 @default.
• W2998955107 hasConceptScore W2998955107C134018914 @default.
• W2998955107 hasConceptScore W2998955107C143998085 @default.
• W2998955107 hasConceptScore W2998955107C151956035 @default.
• W2998955107 hasConceptScore W2998955107C159641895 @default.
• W2998955107 hasConceptScore W2998955107C185592680 @default.
• W2998955107 hasConceptScore W2998955107C2776174234 @default.

• next